Laser Focus World is an industry bedrock—first published in 1965 and still going strong. We publish original articles about cutting-edge advances in lasers, optics, photonics, sensors, and quantum technologies, as well as test and measurement, and the shift currently underway to usher in the photonic integrated circuits, optical interconnects, and copackaged electronics and photonics to deliver the speed and efficiency essential for data centers of the future.

Our 80,000 qualified print subscribers—and 130,000 12-month engaged online audience—trust us to dive in and provide original journalism you won’t find elsewhere covering key emerging areas such as laser-driven inertial confinement fusion, lasers in space, integrated photonics, chipscale lasers, LiDAR, metasurfaces, high-energy laser weaponry, photonic crystals, and quantum computing/sensors/communications. We cover the innovations driving these markets.

Laser Focus World is part of Endeavor Business Media, a division of EndeavorB2B.

Laser Focus World Membership

Never miss any articles, videos, podcasts, or webinars by signing up for membership access to Laser Focus World online. You can manage your preferences all in one place—and provide our editorial team with your valued feedback.

Magazine Subscription

Can you subscribe to receive our print issue for free? Yes, you sure can!

Newsletter Subscription

Laser Focus World newsletter subscription is free to qualified professionals:

The Daily Beam

Showcases the newest content from Laser Focus World, including photonics- and optics-based applications, components, research, and trends. (Daily)

Product Watch

The latest in products within the photonics industry. (9x per year)

Bio & Life Sciences Product Watch

The latest in products within the biophotonics industry. (4x per year)

Laser Processing Product Watch

The latest in products within the laser processing industry. (3x per year)

Get Published!

If you’d like to write an article for us, reach out with a short pitch to Sally Cole Johnson: [email protected]. We love to hear from you.

Photonics Hot List

Laser Focus World produces a video newscast that gives a peek into what’s happening in the world of photonics.

Following the Photons: A Photonics Podcast

Following the Photons: A Photonics Podcast dives deep into the fascinating world of photonics. Our weekly episodes feature interviews and discussions with industry and research experts, providing valuable perspectives on the issues, technologies, and trends shaping the photonics community.

Editorial Advisory Board

  • Professor Andrea M. Armani, University of Southern California
  • Ruti Ben-Shlomi, Ph.D., LightSolver
  • James Butler, Ph.D., Hamamatsu
  • Natalie Fardian-Melamed, Ph.D., Columbia University
  • Justin Sigley, Ph.D., AmeriCOM
  • Professor Birgit Stiller, Max Planck Institute for the Science of Light, and Leibniz University of Hannover
  • Professor Stephen Sweeney, University of Glasgow
  • Mohan Wang, Ph.D., University of Oxford
  • Professor Xuchen Wang, Harbin Engineering University
  • Professor Stefan Witte, Delft University of Technology

Next Gen Diagnostics Expands U.S. Operations With New Lab in Kendall Square

Move positions company at the heart of Cambridge's innovation ecosystem to accelerate growth and collaboration in infection prevention.

CAMBRIDGE, MA / ACCESS Newswire / October 14, 2025 / Next Gen Diagnostics (NGD), a biotechnology company delivering automated whole genome sequencing and bioinformatics to track infection transmission in real time, today announced the relocation of its laboratory to Kendall Square in Cambridge, Massachusetts.

The new space, located at the center of one of the world's most dynamic life sciences hubs, will enable NGD to expand its R&D capabilities, strengthen collaborations with academic and industry partners, and accelerate adoption of its sequencing-based transmission detection technology among hospital systems.

"Kendall Square is synonymous with scientific discovery and collaboration," said Dr. Paul A. Rhodes, CEO and Founder of Next Gen Diagnostics. "This move places NGD in the middle of a thriving community of innovators and reinforces our commitment to transforming infection prevention through real-time genomics."

NGD offers a low-cost integrated on-site sequencing and bioinformatic analysis service to bring practical, implementable sequence-based transmission detection to hospital systems. The system automatically generates actionable reports for infection prevention teams delivered via an intuitive user interface, including both transmission-linked patients and probable root cause. IP teams can focus on confirmation of suspected cause and move to the implementation of actions curtailing further transmission, reducing average length of stay while improving patient experience and medical outcome. By closing the detection gap - where over 90% of hospital transmissions currently go unnoticed1,2 - NGD's platform empowers healthcare providers to intervene earlier and more effectively.

The relocation underscores NGD's growth trajectory as it prepares to deepen its U.S. presence and broaden commercialization in 2025.

1Coll, et al. Science Translational Medicine, 2017
2Sundermann et, al. Clinical Infectious Diseases, 2022

Contact Information

Samantha Kahn
Director of Strategic Marketing
press@nextgen-dx.com

.

SOURCE: Next Gen Diagnostics



View the original press release on ACCESS Newswire

More News

View More

Recent Quotes

View More
Symbol Price Change (%)
AMZN  213.04
-1.43 (-0.67%)
AAPL  252.29
+4.84 (1.96%)
AMD  233.08
-1.48 (-0.63%)
BAC  51.28
+0.84 (1.67%)
GOOG  253.79
+1.91 (0.76%)
META  716.91
+4.84 (0.68%)
MSFT  513.58
+1.97 (0.39%)
NVDA  183.16
+1.35 (0.74%)
ORCL  291.31
-21.69 (-6.93%)
TSLA  439.31
+10.56 (2.46%)
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.